Pancreatic Cancer Research

ResearcherNankai UniversityActive in the last 2 years

Jun Cai

Matched on ORCID iD 0009-0004-5110-1976; OpenAlex author ID A5072433757. Sources: OpenAlex.

Their work

Papers
10 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2016: 1 paper · 2017: 2 papers · 2018: 2 papers · 2019: none · 2020: 3 papers · 2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 10

  1. Explore the Function and Mechanisms of Triptolide in Tenascin-C Mediated Migration and Gemcitabine Resistance in Pancreatic Cancer. Co-author PMID 41253475↗
  2. The COL11A1/Akt/CREB signaling axis enables mitochondrial-mediated apoptotic evasion to promote chemoresistance in pancreatic cancer cells through modulating B… Co-author DOI 10.7150/jca.47032↗
  3. LAMC2 modulates the acidity of microenvironments to promote invasion and migration of pancreatic cancer cells via regulating AKT-dependent NHE1 activity. First author DOI 10.1016/j.yexcr.2020.111984↗
  4. Apolipoprotein E2 modulates cell cycle function to promote proliferation in pancreatic cancer cells via regulation of the c-Myc-p21Waf1 signalling pathway. Co-author DOI 10.1139/bcb-2018-0230↗
  5. Apolipoprotein E2 Promotes the Migration and Invasion of Pancreatic Cancer Cells via Activation of the ERK1/2 Signaling Pathway. Co-author DOI 10.2147/cmar.s284115↗
  6. Artemin regulates CXCR4 expression to induce migration and invasion in pancreatic cancer cells through activation of NF-κB signaling. Co-author DOI 10.1016/j.yexcr.2018.02.008↗
  7. Tenascin-C Modulates Cell Cycle Progression to Enhance Tumour Cell Proliferation through AKT/FOXO1 Signalling in Pancreatic Cancer. Co-author DOI 10.7150/jca.25926↗
  8. Fractalkine/CX3CR1 induces apoptosis resistance and proliferation through the activation of the AKT/NF-κB cascade in pancreatic cancer cells. First author DOI 10.1002/cbf.3278↗
  9. Tenascin-C induces migration and invasion through JNK/c-Jun signalling in pancreatic cancer. Co-author DOI 10.18632/oncotarget.20160↗
  10. Nerve growth factor regulates CD133 function to promote tumor cell migration and invasion via activating ERK1/2 signaling in pancreatic cancer. Co-author DOI 10.1016/j.pan.2016.09.005↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xiaohong Shen · 9 shared papers, 2016–2021 · strength 0.96
  2. Shaoxia Du · 8 shared papers, 2017–2021 · strength 0.90
  3. Hui Wang · 8 shared papers, 2017–2021 · strength 0.90
  4. Na Gu · 1 shared paper, 2025 · strength 0.30
  5. Juan Wang · 3 shared papers, 2017–2020 · strength 0.30
  6. Beibei Xin · 4 shared papers, 2016–2018 · strength 0.29
  7. Wei Wei · 2 shared papers, 2017–2020 · strength 0.20
  8. Wei Wei · 1 shared paper, 2020 · strength 0.15
  9. Xiaodan He · 1 shared paper, 2016 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.